Multicenter, Double Blind,Randomized, 2-period, Crossover Study to Compare Ezetimibe/Simvastatin (10mg/10 mg) Combination Tablet Versus Simvastatin 80mg Tablet on Postprandial Arterial Endothelial Function in Patients With Metabolic Syndrome
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2013
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Simvastatin
- Indications Dyslipidaemias; Metabolic syndrome; Obesity
- Focus Pharmacodynamics
- Acronyms PANACEA
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
- 23 Nov 2010 Status changed from active, no longer recruiting to completed.
- 09 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.